From: Functional and structural characteristics of anticancer peptide Pep27 analogues
Peptide | Amino acid sequences | Remarks (substitution) | RT (min) |
---|---|---|---|
Pep27 | MRKEFHNVLSSGQLLADKRPARDYNRK | (2R→W), (4E→W) | 14.54 |
Pep27anal1 | MWKWFHNVLSSWQLLADKRPARDYNRK | (2R→W), (4E→W) | 18.67 |
Pep27anal2 | MWKWFHNVLSWWWLLADKRPARDYNRK | (2R→W), (4E→W), (11S→W), (13Q→W) | 22.50 |
Pep27anal3 | MRKWFHNVLSSGQLLADKWPAWDYNRK | (4E→W), (19R→W), (22R→W), (26R→W) | 20.08 |
Pep27anal4 | MWKEFHNVLSSGQLLADKRWARWYNRW | (2R→W), (20P→W), (23D→W), (27K→W) | 19.15 |
Pep27anal5 | MWKWFHNVLSSGQLLADKWWAWWYNWW | (2R→W), (4E→W), (19R→W), (20P→W), (22R→W), (23D→W), (26R→W), (27K→W) | 19.17 |